Yoeri Bemelmans

Chapter 8 132 Table 1. Continued. Author(s) N Arthroplasty Study design AEs Lovald et al.[28] 5.401 TKA Case series NA** Lovald et al.[30] 102.684 TKA Case controlled DVT (4.8%), dislocation (1.1%), loosening (2.1%), infection (4.5%), mortality (2.4%), pain in joint (46,3%), revision (2.1%), stiffness (8.2%), mechanical complication (3.4%), wound (1.1%) Table 2 . Expert opinion and literature based patient selection criteria for OJA. Inclusion criteria Expert opinion General Able and willing to participate, understanding the OJA protocol and care must be provided during the first postoperative days. Exclusion criteria General None Cardiology Coumarin-derivative usage based on atrial fibrillation or prosthetic valve, bridging anticoagulation, NYHA classification[14] III or IV. Pulmonology Lung fibrosis, emphysema, carcinoma, pulmonary hypertension or embolism. Internal medicine Extensive edema, chronic usage of prednisolone, severe renal function disorders, DM type I. Geriatrics History of (frequent) falling in the past three months, cognitive function disorders (e.g. history of delirium, dementia, memory difficulties), need for additional inpatient rehabilitation, polypharmacy and/or substance abuse. Urology Pre-existing voiding difficulties, preoperative use of urologic medication. Neurology Severe mobility disorders (e.g. loss function due to cerebrovascular accident, Parkinson, peripheral neurologic function disorders). Psychiatry No criteria were given. Patient selection criteria According to recent literature, patients, who are able and willing to participate, with a lowASA classification (<III), undergoing primary arthroplasty, age <75 andwith support at home during the first postoperative days are eligible candidates for OJA. Patients with a high ASA classification (>II), bleeding disorders, poorly controlled and/or severe cardiac (e.g. heart failure, arrhythmia) or pulmonary (e.g. embolism, respiratory failure) comorbidities, uncontrolled DM (type I or II), a high BMI (>30 m2/kg), chronic opioid consumption, functional neurological impairments, dependent functional status, chronic/end-stage renal disease and/or reduced preoperative cognitive capacity should be excluded from OJA.